VOLITIONRX LTD

Analysis for Ticker: VNRX

Volitionrx Limited claims to build blood tests to find cancer and sepsis using high-tech names like Nu.Q Net and Nu.Q Vet. It looks like a scientific savior, but the current reality is a hollowed-out machine. On 28/04/2026, the company performed a desperate mathematical trick called a reverse stock split, crushing twenty shares into a single one just to keep the price looking high enough to stay on the exchange. The stock currently carries a BC label, which stands for Below Compliance, a public warning that the business is failing the basic financial health rules of the market. The math is a disaster because the company is burning through its final fumes while a debt predator is contractually guaranteed to suck out every penny of new demand. The current price of 2,64$ is a complete illusion, hiding the fact that the company is being eaten alive from the inside by its own financing agreements.